Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Case Study: Achieving WHO GMP Certification in a Pharmaceutical Facility

Posted on December 27, 2024 By digi

Case Study: Achieving WHO GMP Certification in a Pharmaceutical Facility

How a Pharmaceutical Facility Achieved WHO GMP Certification: A Case Study

Introduction to WHO GMP Certification

Achieving WHO GMP certification is a significant milestone for pharmaceutical manufacturers, signifying adherence to the highest standards of quality, safety, and efficacy. The certification not only builds trust among regulators, healthcare providers, and patients but also opens the door to global markets. This case study explores the journey of a pharmaceutical facility toward obtaining WHO GMP certification, highlighting the challenges, strategies, and benefits realized during the process.

This real-world example serves as a guide for other facilities aiming to achieve WHO GMP certification, emphasizing practical steps and lessons learned.

Overview of the Pharmaceutical Facility

The facility in focus is a mid-sized pharmaceutical manufacturer located in South Asia, specializing in the production of generic drugs and over-the-counter (OTC) medicines. The company aimed to achieve WHO GMP certification to expand its market presence globally and meet international regulatory requirements.

Initial Assessment and Challenges

Before embarking on the certification process, the facility conducted a comprehensive gap analysis to identify areas requiring improvement. Key challenges included:

  • Outdated Infrastructure: Existing facilities and equipment did not fully comply with
WHO GMP standards.
  • Inconsistent Documentation: Gaps in record-keeping practices led to difficulties in demonstrating traceability.
  • Limited Training: Staff lacked sufficient knowledge of WHO GMP principles and practices.
  • Supply Chain Variability: Quality inconsistencies in raw materials sourced from multiple suppliers.
  • Strategies for Achieving WHO GMP Certification

    The facility developed a multi-phase strategy to address these challenges and align its operations with WHO GMP guidelines:

    1. Upgrading Infrastructure

    Modernizing the facility was a critical first step. Actions taken included:

    • Facility Redesign: Implementing modular layouts to segregate production areas and prevent cross-contamination.
    • Equipment Upgrade: Installing automated systems for critical processes such as mixing, filling, and packaging.
    • Environmental Controls: Enhancing cleanroom standards and implementing real-time monitoring systems for temperature, humidity, and air quality.

    2. Strengthening Documentation Practices

    The facility adopted robust documentation practices to meet WHO GMP requirements. Key initiatives included:

    • Standard Operating Procedures (SOPs): Developing clear and detailed SOPs for all processes.
    • Electronic Batch Records (EBRs): Transitioning from paper-based records to digital systems for improved traceability and accuracy.
    • Audit Trails: Implementing systems to track changes in records and ensure accountability.

    3. Implementing Quality Assurance Systems

    To ensure consistent product quality, the facility established comprehensive quality assurance (QA) systems, including:

    • In-Process Controls: Monitoring critical parameters during production to identify deviations promptly.
    • Final Product Testing: Conducting rigorous quality control tests before releasing products to the market.
    • Corrective and Preventive Actions (CAPA): Addressing root causes of deviations to prevent recurrence.

    4. Enhancing Personnel Training

    A well-trained workforce was essential for achieving compliance. Training programs focused on:

    • GMP Principles: Educating staff on the importance of GMP and their roles in maintaining compliance.
    • Role-Specific Training: Providing targeted instruction for production, quality control, and maintenance teams.
    • Continuous Education: Offering regular refresher courses and updates on GMP best practices.

    5. Optimizing Supply Chain Management

    The facility improved its supply chain processes to ensure consistent quality of raw materials. Key measures included:

    • Supplier Qualification: Conducting audits and evaluations of raw material suppliers.
    • Material Testing: Implementing comprehensive testing protocols for incoming materials.
    • Traceability Systems: Establishing detailed records for all materials used in production.

    The Certification Process

    After implementing these changes, the facility applied for WHO GMP certification. The certification process involved:

    • Pre-Inspection Audit: Conducting an internal audit to identify and address any remaining gaps.
    • Regulatory Inspection: Hosting WHO inspectors for a comprehensive review of facilities, processes, and documentation.
    • Corrective Actions: Addressing minor observations and providing evidence of compliance.

    The facility successfully passed the inspection and received WHO GMP certification within six months of applying.

    Benefits Realized After Certification

    Achieving WHO GMP certification brought significant advantages to the facility, including:

    1. Expanded Market Access

    The certification enabled the facility to export its products to over 20 countries, increasing revenue and market presence.

    2. Improved Product Quality

    Enhanced processes and controls resulted in consistent product quality and reduced deviations.

    3. Regulatory Trust

    Demonstrating compliance with WHO GMP built trust with regulators, facilitating faster product approvals.

    4. Operational Efficiency

    Standardized processes and automated systems improved productivity and reduced waste.

    5. Employee Engagement

    Comprehensive training programs fostered a culture of quality and accountability among staff.

    Key Takeaways and Lessons Learned

    The facility’s journey to WHO GMP certification offers valuable insights for other manufacturers:

    • Plan Strategically: Conduct a thorough gap analysis and prioritize critical upgrades.
    • Invest in Training: Ensure all employees understand GMP principles and their responsibilities.
    • Leverage Technology: Adopt digital tools to streamline documentation and monitoring.
    • Engage with Regulators: Collaborate with regulatory authorities to address concerns and align expectations.

    Conclusion

    Achieving WHO GMP certification is a rigorous but rewarding process that ensures compliance with global quality standards and opens new opportunities for growth. This case study demonstrates the importance of strategic planning, robust quality systems, and continuous improvement in achieving certification. By following these principles, pharmaceutical manufacturers can enhance product quality, gain regulatory trust, and expand their market presence, contributing to better healthcare outcomes worldwide.

    WHO GMP Guidelines Tags:cGMP (current Good Manufacturing Practice), Corrective and Preventive Actions (CAPA) for GMP, EMA GMP standards, FDA GMP guidelines, GMP audits, GMP certification, GMP compliance, GMP for clinical trials, GMP for sterile products, GMP in biopharmaceuticals, GMP inspections, GMP training for employees, GMP violations, Good Manufacturing Practice (GMP), Health Canada GMP regulations, Lean manufacturing and GMP, MHRA GMP requirements, NMPA GMP (China), Pharma GMP, Pharmaceutical manufacturing under GMP, PMDA GMP (Japan), Quality Management Systems (QMS) in pharma, Risk management in GMP, Schedule M, Sustainability in GMP, TGA GMP (Australia), WHO GMP guidelines

    Post navigation

    Previous Post: Computer System Validation in GMP: A Practical Guide
    Next Post: How TGA GMP Standards Support the Launch of New Pharmaceutical Products

    Quick Guide

    • GMP Basics
      • Introduction to GMP
      • What is cGMP?
      • Key Principles of GMP
      • Benefits of GMP in Pharmaceuticals
      • GMP vs. GxP (Good Practices)
    • Regulatory Agencies & Guidelines
      • WHO GMP Guidelines
      • FDA GMP Guidelines
      • MHRA GMP Guidelines
      • SCHEDULE – M – Revised
      • TGA GMP Guidelines
      • Health Canada GMP Regulations
      • NMPA GMP Guidelines
      • PMDA GMP Guidelines
      • EMA GMP Guidelines
    • GMP Compliance & Audits
      • How to Achieve GMP Certification
      • GMP Auditing Process
      • Preparing for GMP Inspections
      • Common GMP Violations
      • Role of Quality Assurance
    • Quality Management Systems (QMS)
      • Building a Pharmaceutical QMS
      • Implementing QMS in Pharma Manufacturing
      • CAPA (Corrective and Preventive Actions) for GMP
      • QMS Software for Pharma
      • Importance of Documentation in QMS
      • Integrating GMP with QMS
    • Pharmaceutical Manufacturing
      • GMP in Drug Manufacturing
      • GMP for Biopharmaceuticals
      • GMP for Sterile Products
      • GMP for Packaging and Labeling
      • Equipment and Facility Requirements under GMP
      • Validation and Qualification Processes in GMP
    • GMP Best Practices
      • Total Quality Management (TQM) in GMP
      • Continuous Improvement in GMP
      • Preventing Cross-Contamination in Pharma
      • GMP in Supply Chain Management
      • Lean Manufacturing and GMP
      • Risk Management in GMP
    • Regulatory Compliance in Different Regions
      • GMP in North America (FDA, Health Canada)
      • GMP in Europe (EMA, MHRA)
      • GMP in Asia (PMDA, NMPA, KFDA)
      • GMP in Emerging Markets (GCC, Latin America, Africa)
      • GMP in India
    • GMP for Small & Medium Pharma Companies
      • Implementing GMP in Small Pharma Businesses
      • Challenges in GMP Compliance for SMEs
      • Cost-effective GMP Compliance Solutions for Small Pharma Companies
    • GMP in Clinical Trials
      • GMP Compliance for Clinical Trials
      • Role of GMP in Drug Development
      • GMP for Investigational Medicinal Products (IMPs)
    • International GMP Inspection Standards and Harmonization
      • Global GMP Inspection Frameworks
      • WHO Prequalification and Inspection Systems
      • US FDA GMP Inspection Programs
      • EMA and EU GMP Inspection Practices
      • PIC/S Role in Harmonized Inspections
      • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
    • GMP Blog

    Latest Posts

    • GMP-cGMP Regulations & Global Standards
      • FDA cGMP Regulations for Drugs & Biologics
      • cGMP Requirements for Pharmaceutical Manufacturers
      • ICH Q7 and API GMP Expectations
      • Global & ISO-Based GMP Standards
      • GMP for Medical Devices & Combination Products
      • GMP for Pharmacies & Hospital Pharmacy Settings
    • Applied GMP in Pharma Manufacturing & Operations
      • GMP for Pharmaceutical Drug Product Manufacturing
      • GMP for Biotech & Biologics Manufacturing
      • GMP Documentation
      • GMP Compliance
      • GMP for APIs & Bulk Drugs
      • GMP Training
    • Computer System Validation (CSV) & GxP Computerized Systems
      • CSV Fundamentals in Pharma & Biotech
      • FDA CSV Guidance & 21 CFR Part 11 Alignment
      • GAMP 5 & Risk-Based Validation Approaches
      • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
      • CSV Documentation
      • CSV for Regulated Equipment & Embedded Systems
    • Data Integrity & 21 CFR Part 11 Compliance
      • Data Integrity Principles in cGMP Environments
      • FDA Data Integrity Guidance & Expectations
      • 21 CFR Part 11 – Electronic Records & Signatures
      • Data Integrity in GxP Computerized Systems
      • Data Integrity Audits
    • Pharma GMP & Good Manufacturing Practice
      • FDA 483, Warning Letters & GMP Inspections
      • Data Integrity, ALCOA+ & Part 11 / Annex 11
      • Process Validation, CPV & Cleaning Validation
      • Contamination Control & Annex 1
      • PQS / QMS / Deviations / CAPA / OOS–OOT
      • Documentation, Batch Records & GDP
      • Sterility, Microbiology & Utilities
      • CSV, GAMP 5 & Automation
      • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
      • Supply Chain, Warehousing, Cold Chain & GDP
    Widget Image
    • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

      Never Assign Batch Release Responsibilities… Read more

    • Manufacturing & Batch Control
      • GMP manufacturing process control
      • Batch Manufacturing record requirements
      • Master Batch record template for pharmaceuticals
      • In Process control checks in tablet manufacturing
      • Line clearance procedure before batch start
      • Batch reconciliation in pharmaceutical manufacturing
      • Yield reconciliation GMP guidelines
      • Segregation of different strength products GMP
      • GMP controls for high potency products
      • Cross Contamination prevention in manufacturing
      • Line clearance checklist for production
      • Batch documentation review before qa release
      • Process parameters control limits in pharma
      • Equipment changeover procedure GMP
      • Batch manufacturing deviation handling
      • GMP expectations for batch release
      • In Process sampling plan for tablets
      • Visual inspection of dosage forms GMP requirements
      • In Process checks for filled vials
      • Startup and Shutdown procedure for manufacturing line
      • GMP requirements for blending and mixing operations
      • Process Control strategy in pharmaceutical manufacturing
      • Uniformity of dosage units in process controls
      • GMP checklist for oral solid dosage manufacturing
      • Process Control
      • Batch Documentation
      • Master Batch Records
      • In-Process Controls
      • Line Clearance
      • Yield & Reconciliation
      • Segregation & Mix-Ups
      • High Potency Products
      • Cross Contamination Control
      • Line Clearance
      • Batch Review
      • Process Parameters
      • Equipment Changeover
      • Deviations
      • Batch Release
      • In-Process Sampling
      • Visual Inspection
      • In-Process Checks for Vials
      • Start-Up & Shutdown
      • Blending & Mixing
      • Control Strategy
      • Dosage Uniformity
      • Hold Time Studies
      • OSD GMP Checklist
    • Cleaning & Contamination Control
    • Warehouse & Material Handling
      • Warehouse GMP
      • Material Receipt
      • Sampling
      • Status Labelling
      • Storage Conditions
      • Rejected & Returned
      • Reconciliation
      • Controlled Drugs
      • Dispensing
      • FIFO & FEFO
      • Cold Chain
      • Segregation
      • Pest Control
      • Env Monitoring
      • Palletization
      • Damaged Containers
      • Stock Verification
      • Sampling & Weighing Areas
      • Issue to Production
      • Traceability
      • Printed Materials
      • Intermediates
      • Cleaning & Housekeeping
      • Status Tags
      • Warehouse Audit
    • QC Laboratory & Testing
      • Analytical Method Validation
      • Chromatography Systems
      • Dissolution Testing
      • Assay & CU
      • Impurity Profiling
      • Stability & QC
      • OOS Investigations
      • OOT Trending
      • Sample Management
      • Reference Standards
      • Equipment Calibration
      • Instrument Qualification
      • LIMS & Electronic Data
      • Data Integrity
      • Microbiology QC
      • Sterility & Endotoxin
      • Environmental Monitoring
      • QC Documentation
      • Results Review
      • Method Transfer
      • Forced Degradation
      • Compendial Methods
      • Cleaning Verification
      • QC Deviations & CAPA
      • QC Lab Audits
    • Manufacturing & In-Process Control
      • Batch Manufacturing Records
      • Batch Manufacturing Records
      • Line Clearance
      • In-Process Sampling & Testing
      • Yield & Reconciliation
      • Granulation Controls
      • Blending & Mixing
      • Tablet Compression Controls
      • Capsule Filling Controls
      • Coating Process Controls
      • Sterile & Aseptic Processing
      • Filtration & Sterile Filtration
      • Visual Inspection of Parenteral
      • Packaging & Labelling Controls
      • Rework & Reprocessing
      • Hold Time for Bulk & Intermediates
      • Manufacturing Deviations & CAPA
    • Documentation, Training & QMS
      • SOP & Documentation Control
      • Training & Competency Management
      • Change Control & QMS Lifecycle
      • Internal Audits & Self-Inspection
      • Quality Metrics, Risk & Management Review
    • Production SOPs
    • QC Laboratory SOPs
      • Sample Management
      • Analytical Methods
      • HPLC & Chromatography
      • OOS & OOT
      • Data Integrity
      • Documentation
      • Equipment
    • Warehouse & Materials SOPs
      • Material Receipt
      • Sampling
      • Storage
      • Dispensing
      • Rejected & Returned
      • Cold Chain
      • Stock Control
      • Printed Materials
      • Pest & Housekeeping
    • Cleaning & Sanitization SOPs
    • Equipment & Qualification SOPs
    • Documentation & Data Integrity SOPs
    • Deviation/OOS/CAPA SOPs
      • Deviation Management
      • Root Cause
      • CAPA
      • OOS/OOT
      • Complaints
      • Recall
    • Training & Competency SOPs
      • Training System
      • Role-Based Training
      • OJT
      • Refresher Training
      • Competency
    • QA & QMS Governance SOPs
      • Quality Manual
      • Management Review
      • Internal Audit
      • Risk Management
      • Vendors & Outsourcing
    • About Us
    • Privacy Policy & Disclaimer
    • Contact Us

    Copyright © 2025 Pharma GMP.

    Powered by PressBook WordPress theme